Breaking News Instant updates and real-time market news.

Stericycle management to meet with Barrington

Meetings to be held in Portland on May 15 and in San Francisco on May 16 hosted by Barrington.

16

May

12

Jun

SRCLStericycle

$63.88

-0.24 (-0.37%)

02/13/18

BARD

02/13/18UPGRADEBARDNeutral

Stericycle upgraded to Neutral from Underperform at Baird

02/13/18

BARD

02/13/18UPGRADETarget $73BARDNeutral

Stericycle upgraded to Neutral at Baird

As previously reported, Baird analyst David Manthey upgraded Stericycle to Neutral from Underperform. The analyst said he continues to have a negative bias on the company's fundamentals, but he sees a more balanced risk/reward following the stock's relative underperformance to the market. Manthey raised his price target to $73 from $62 on Stericycle shares.

02/22/18

RBCM

02/22/18NO CHANGETarget $61RBCMUnderperform

Stericycle price target lowered to $61 from $75 at RBC Capital

RBC Capital analyst Gary Bisbee lowered his price target on Stericycle to $61 and kept his Underperform rating following the company's Q4 earnings and FY18 guidance. Bisbee says the outlook suggests that weaker revenue, cost pressures, and investments will weigh on earnings and cash flow, adding that he has little confidence in the company's execution.

02/22/18

STFL

02/22/18NO CHANGETarget $90STFLBuy

Stifel reiterates Buy rating on Stericycle after 'slight' Q4 miss

Stifel analyst Michael Hoffman reiterated his Buy rating on Stericycle following the company's Q4 report, noting its sales beat and "slight" EPS miss. The company's conventional free cash flow "remains sound" with a five year CAGR forecast of over 10%, added Hoffman, who maintains his $90 price target on Stericycle shares, which are down 16.5% to $62.50 in early trading.